Log In or Register
HomeLocal NewsState NewsSportsOpinionObituariesAgriculture
Quick Links
  Home
  My Bulletin
  Contact The Bulletin

Marketplace
  Display Ads
  Classifieds
  Dir. of Advertisers

Opinion

Mail: Gas is too high

Congrats Australia, for repealing carbon tax

More opinion

Ag News

Gudmundsen Sandhills Lab to host open house Aug. 20

NFU: Say no to Tyson-Hillshire merger

More Ag News


Email Article | Print Article
News - State/Regional News
 
Settlement with Johnson & Johnson: $9.2 Million for NebraskaTell North Platte what you think
 

Nebraska Attorney General Jon Bruning announced a settlement Monday with Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., regarding sales of the antipsychotic drugs, Risperdal and Invega.

NebraskaLand National BankYou've got a
facebook Request!
CLICK HERE!

Nebraska contended the companies promoted the drugs for off-label uses and made false and misleading statements about their safety and efficacy.

In addition, illegal kickbacks were paid to health care professionals and long-term care pharmacy providers to induce promotion and prescribing of Risperdal to children, adolescents and the elderly without FDA approval for use in these patient populations, Bruning said.

The manufacturers’ conduct caused false and/or fraudulent claims to be submitted to, or caused purchases by, government-funded health care programs including the state Medicaid program.

“Drug manufacturers must be held accountable for improper marketing of their products,” said Bruning. “This settlement helps to ensure protocol will be followed in the future.”

Nebraska’s share of the settlement is $9.2 million. The recovered funds will reimburse the Nebraska Medicaid program for losses and can be applied to legal fees specific to each case, Bruning said.

As a condition of the settlement, Johnson & Johnson will enter into a corporate integrity agreement with the U.S. Department of Health and Human Services, Office of the Inspector General, which will closely monitor the company’s future marketing and sales practices.


Medicaid fraud, patient abuse unit

Since its inception in 2004, the Attorney General’s Medicaid Fraud and Patient Abuse Unit has recovered more than $70 million from violating service providers and drug companies.

When the unit was established, Bruning promised the Legislature it would be self-funding in three years. The unit’s annual recoveries surpassed its operating budget starting in 2006, a year ahead of schedule.


Like this story to send to your facebook

The North Platte Bulletin - Published 11/4/2013
Copyright © 2013 northplattebulletin.com - All rights reserved.
Flatrock Publishing, Inc. - 1300 E 4th St., Suite F - North Platte, NE 69101
 
Show me Talk Back during this visit
 
 

Copyright © 2003 - 2014 northplattebulletin.com
All rights reserved.

Flatrock Publishing, Inc.
1300 E 4th St., Suite F
North Platte, NE 69101

 
Your Ip Address - 54.197.52.154
North Platte, Nebraska